I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Camrelizumab plus famitinib in patients with recurrent or m..:
Xi Ding
;
Yi-Jun Hua
;
Xiong Zou
...
http://www.sciencedirect.com/science/article/pii/S2589537023002201. , 2023
Link:
https://doi.org/10.1016/j.eclinm.2023.102043
RT Journal T1
Camrelizumab plus famitinib in patients with recurrent or metastatic nasopharyngeal carcinoma treated with PD-1 blockade: data from a multicohort phase 2 studyResearch in context
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3354f790c5364e4ea88154d8ea5f0184&Exemplar=1&LAN=DE A1 Xi Ding A1 Yi-Jun Hua A1 Xiong Zou A1 Xiao-Zhong Chen A1 Xi-Mei Zhang A1 Bei Xu A1 Yan-Feng Ouyang A1 Zi-Wei Tu A1 Hui-Feng Li A1 Chong-Yang Duan A1 Wei-Jing Zhang A1 Rui You A1 You-Ping Liu A1 Yong-Long Liu A1 Qi Yang A1 Pei-Yu Huang A1 Shu-Ni Wang A1 Jia Fan A1 Ming-Yuan Chen PB Elsevier YR 2023 K1 Camrelizumab K1 Famitinib K1 Nasopharyngeal carcinoma K1 PD-1 inhibitor K1 Retreatment K1 VEGFR K1 Medicine (General) K1 R5-920 JF http://www.sciencedirect.com/science/article/pii/S2589537023002201 LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2023.102043 DO https://doi.org/10.1016/j.eclinm.2023.102043 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)